InvestorsHub Logo
Followers 74
Posts 17633
Boards Moderated 0
Alias Born 09/03/2001

Re: None

Tuesday, 11/22/2011 12:02:00 PM

Tuesday, November 22, 2011 12:02:00 PM

Post# of 346551
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath and Peregrine Trial Data...
Seeking Alpha
Bavituximab has shown promise in several oncology indications but is currently in ... The front-line NSCLC Phase II trial is evaluating Bavituximab with ...

(I couldn't copy this but here's the site)


http://seekingalpha.com/article/309606-lipid-signaling-could-shake-up-biotech-in-2012-with-pending-lpath-and-peregrine-trial-data
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News